Rhythm Pharmaceuticals Stock
Price
Target price
€37.80
€37.80
-3.550%
-1.4
-3.550%
€45.98
03.07.24 / Tradegate
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Rhythm Pharmaceuticals Stock
Heavy losses for Rhythm Pharmaceuticals today as the stock fell by -€1.400 (-3.550%).
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Rhythm Pharmaceuticals.
As a result the target price of 45 € shows a slightly positive potential of 19.05% compared to the current price of 37.8 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | -3.550% | 1.070% | 6.780% | 126.347% | -11.268% | - | - |
| Ardelyx Inc. | -0.800% | -14.425% | -22.883% | 61.184% | -15.225% | -26.866% | - |
| Evolus Inc | -4.020% | -2.051% | -16.957% | 48.062% | 5.525% | -9.048% | - |
| Krystal Biotech | -1.630% | -3.695% | 8.994% | 53.458% | 41.552% | - | - |
Comments
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Needham & Company LLC from $50.00 to $46.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat